MX9200754A - Tratamiento de cancer en los ovarios. - Google Patents
Tratamiento de cancer en los ovarios.Info
- Publication number
- MX9200754A MX9200754A MX9200754A MX9200754A MX9200754A MX 9200754 A MX9200754 A MX 9200754A MX 9200754 A MX9200754 A MX 9200754A MX 9200754 A MX9200754 A MX 9200754A MX 9200754 A MX9200754 A MX 9200754A
- Authority
- MX
- Mexico
- Prior art keywords
- topotecan
- pharmaceutical composition
- human
- composition
- ovaries
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65894891A | 1991-02-21 | 1991-02-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9200754A true MX9200754A (es) | 1992-08-01 |
Family
ID=24643386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9200754A MX9200754A (es) | 1991-02-21 | 1992-02-21 | Tratamiento de cancer en los ovarios. |
Country Status (13)
| Country | Link |
|---|---|
| EP (3) | EP1690542A3 (es) |
| JP (1) | JP2778632B2 (es) |
| KR (1) | KR930702983A (es) |
| AT (2) | ATE444755T1 (es) |
| AU (1) | AU663312B2 (es) |
| CA (1) | CA2103708C (es) |
| DE (2) | DE69233793D1 (es) |
| DK (2) | DK0572557T3 (es) |
| ES (2) | ES2334178T3 (es) |
| HK (1) | HK1012265A1 (es) |
| MX (1) | MX9200754A (es) |
| PT (1) | PT100156B (es) |
| WO (1) | WO1992014469A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101255406B (zh) * | 2005-04-22 | 2010-05-26 | 李红霞 | 人卵巢癌耐药细胞株 |
| ES2371171B1 (es) * | 2010-06-08 | 2012-11-16 | Consejo Superior De Investigaciones Científicas (Csic) | Derivados de camptotecina como agentes antitumorales. |
| CN102477042A (zh) * | 2010-11-26 | 2012-05-30 | 复旦大学 | 10-羟基喜树碱衍生物及其制备方法和用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5004758A (en) | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
-
1992
- 1992-02-07 ES ES92907833T patent/ES2334178T3/es not_active Expired - Lifetime
- 1992-02-07 DK DK92907833.5T patent/DK0572557T3/da active
- 1992-02-07 KR KR1019930702490A patent/KR930702983A/ko not_active Application Discontinuation
- 1992-02-07 AT AT92907833T patent/ATE444755T1/de active
- 1992-02-07 DE DE69233793T patent/DE69233793D1/de not_active Expired - Lifetime
- 1992-02-07 EP EP05076846A patent/EP1690542A3/en not_active Withdrawn
- 1992-02-07 JP JP4507268A patent/JP2778632B2/ja not_active Expired - Lifetime
- 1992-02-07 WO PCT/US1992/001028 patent/WO1992014469A1/en active Application Filing
- 1992-02-07 EP EP05076845A patent/EP1707568B1/en not_active Expired - Lifetime
- 1992-02-07 EP EP92907833A patent/EP0572557B1/en not_active Expired - Lifetime
- 1992-02-07 DE DE69233773T patent/DE69233773D1/de not_active Expired - Lifetime
- 1992-02-07 ES ES05076845T patent/ES2349037T3/es not_active Expired - Lifetime
- 1992-02-07 DK DK05076845.6T patent/DK1707568T3/da active
- 1992-02-07 AU AU14616/92A patent/AU663312B2/en not_active Expired
- 1992-02-07 AT AT05076845T patent/ATE476182T1/de active
- 1992-02-07 CA CA002103708A patent/CA2103708C/en not_active Expired - Lifetime
- 1992-02-21 MX MX9200754A patent/MX9200754A/es unknown
- 1992-02-21 PT PT100156A patent/PT100156B/pt not_active IP Right Cessation
-
1998
- 1998-12-15 HK HK98113535.8A patent/HK1012265A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69233773D1 (de) | 2009-11-19 |
| EP1707568B1 (en) | 2010-08-04 |
| JP2778632B2 (ja) | 1998-07-23 |
| EP1707568A3 (en) | 2008-03-26 |
| ES2349037T3 (es) | 2010-12-22 |
| PT100156B (pt) | 1999-09-30 |
| AU1461692A (en) | 1992-09-15 |
| EP0572557A4 (en) | 1993-12-29 |
| EP1690542A3 (en) | 2008-03-26 |
| DK0572557T3 (da) | 2010-02-01 |
| CA2103708A1 (en) | 1992-08-22 |
| AU663312B2 (en) | 1995-10-05 |
| ATE444755T1 (de) | 2009-10-15 |
| EP0572557B1 (en) | 2009-10-07 |
| DE69233793D1 (de) | 2010-09-16 |
| CA2103708C (en) | 2004-04-27 |
| JPH06505740A (ja) | 1994-06-30 |
| EP1690542A2 (en) | 2006-08-16 |
| KR930702983A (ko) | 1993-11-29 |
| PT100156A (pt) | 1993-05-31 |
| HK1012265A1 (en) | 1999-07-30 |
| WO1992014469A1 (en) | 1992-09-03 |
| EP0572557A1 (en) | 1993-12-08 |
| DK1707568T3 (da) | 2010-11-08 |
| ES2334178T3 (es) | 2010-03-05 |
| EP1707568A2 (en) | 2006-10-04 |
| ATE476182T1 (de) | 2010-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69233169D1 (de) | Cisplatin und Topotecan enthaltende Zusammensetzung als antitumor. | |
| HU0301601D0 (en) | Bis(n-substituted)-staurosporine derivatives, their use and pharmaceutical composition containing thereof | |
| AU591125B2 (en) | Therapeutic nucleosides | |
| UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
| ZA928011B (en) | Transdermal administration of melatonin. | |
| GR3015431T3 (en) | Use of acetyl L-carnitine in the therapeutic treatment of coma. | |
| MX9200754A (es) | Tratamiento de cancer en los ovarios. | |
| EP0420872A4 (en) | Therapeutic uses of 2',5'-oligoadenylate derivatives | |
| AU584431B2 (en) | Ergoline derivatives | |
| PT1250926E (pt) | Utilização de uma s-camptotecina insolúvel em água, com um anel de lactona fechado, no fabrico de um medicamento para o tratamento do cancro do cólon | |
| GB8819626D0 (en) | Pharmaceutical composition for treatment of tumours | |
| OA09790A (en) | "Paromomycin or its derivatives or salts thereof for parenteral treatment of human parasitic diseases". |